Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 301–400 of 1,005
Do all lung adenocarcinomas follow a stepwise progression?
Yatabe, Y., Borczuk, A., & Powell, C. A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.021 · Cited by 135
Oncogene-induced Cellular Senescence
Chandeck, C., & Mooi, W. J. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181c66f4e · Cited by 116
Podsypanina, K., Politi, K., Beverly, L. J., & Varmus, H. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801197105 · Cited by 128
Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor
Neault, M., Mallette, F. A., Vogel, G., Michaud-Levesque, J., & Richard, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks764 · Cited by 119
Mallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 120
“Recent studies indicate that cellular senescence plays a crucial role in the suppression of oncogene-induced tumorigenesis in vivo (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Lin et al., 2010; Michaloglou et al., 2005; Ventura et al., 2007; Xue et al., 2007).”
BackgroundConserved and novel functions of programmed cellular senescence during vertebrate development
Davaapil, H., Brockes, J. P., & Yun, M. H. (2016) · Development · doi:10.1242/dev.138222 · Cited by 124
“As such, it constitutes a powerful anti-tumourigenic mechanism (Braig et al., 2005; Collado et al., 2005).”
BackgroundSmall-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Wiley, C. D., Schaum, N., Alimirah, F., Lopez-Dominguez, J. A., Orjalo, A. V., Scott, G., Desprez, P.-Y., Benz, C., Davalos, A. R., & Campisi, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20000-4 · Cited by 124
The role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 143
“neoplasms in check [188–195].”
Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes
Wang, T., Notta, F., Navab, R., Joseph, J., Ibrahimov, E., Xu, J., Zhu, C.-Q., Borgida, A., Gallinger, S., & Tsao, M.-S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0192 · Cited by 123
“Cell lines, tissue, and mouse strains This study was approved by the Research Ethics Board of the UniversityHealthNetwork (13-6377).”
MethodLong noncoding RNAs in aging and age-related diseases
Kour, S., & Rath, P. C. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.001 · Cited by 127
Cellular Senescence and the Immune System in Cancer
Prieto, L. I., & Baker, D. J. (2019) · Gerontology · doi:10.1159/000500683 · Cited by 120
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
“In order to overcome the negative effects of TIS in cancer treatment, the concept of combining senescence-inducing therapies and removal of senescent cells, both normal and tumor derived, or manipulating the paracrine effects of SASP is proposed (Collado et al., 2005; Pribluda et al., 2013; Widemann and Italiano, 2018…”
BackgroundA common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 136
The STAT3 oncogene as a predictive marker of drug resistance
Barré, B., Vigneron, A. M., Perkins, N. D., Roninson, I. B., Gamelin, E. C., & Coqueret, O. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.001 · Cited by 131
Leontieva, O. V., & Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.26130 · Cited by 117
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
“In other experimental settings, unlocking low-level oncogenic Ras expression from its endogenous alleles by recombining a transcriptional lox-stop-lox (LSL) cassette demonstrably resulted in OIS in the lung or the pancreas (Collado et al., 2005).”
BackgroundPancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?
Rooman, I., & Real, F. X. (2012) · Gut · doi:10.1136/gut.2010.235804 · Cited by 120
Lau, L., Porciuncula, A., Yu, A., Iwakura, Y., & David, G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00586-18 · Cited by 119
Huck, J. J., Zhang, M., McDonald, A., Bowman, D., Hoar, K. M., Stringer, B., Ecsedy, J., Manfredi, M. G., & Hyer, M. L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0300 · Cited by 117
“showed an increase in DcR2 staining in senescent adenomas (23).”
BackgroundCellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 114
Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis
Guerrieri, F., Belloni, L., Pediconi, N., & Levrero, M. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345721 · Cited by 128
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic
Galiana, I., Lozano-Torres, B., Sancho, M., Alfonso, M., Bernardos, A., Bisbal, V., Serrano, M., Martínez-Máñez, R., & Orzáez, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.045 · Cited by 115
Self-citationIwanaga, K., Yang, Y., Raso, M. G., Ma, L., Hanna, A. E., Thilaganathan, N., Moghaddam, S., Evans, C. M., Li, H., Cai, W.-W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3117 · Cited by 117
The emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 113
The role of cold‐inducible RNA binding protein in cell stress response
Liao, Y., Tong, L., Tang, L., & Wu, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30833 · Cited by 131
“Given that senescent cells were detected in human tumors associated with benign lesions but not in malignant tumors, it is believed that wild-type cells need to overcome or bypass the senescence barrier to become immortal.(90) Oxidative stress response is one of the key regulatory pathways to modulated senescence/immo…”
BackgroundHyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis
Mo, L., Zheng, X., Huang, H.-Y., Shapiro, E., Lepor, H., Cordon-Cardo, C., Sun, T.-T., & Wu, X.-R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30062 · Cited by 116
“DNA microarray analyses not only provided consistent results, but identified several additional senescence-associated markers that were recently described in transgenic mice expressing an activated Ki-ras in lung epithelial cells (2, 28).”
ResultOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Epigenetic Alterations in Human Papillomavirus-Associated Cancers
Soto, D. R., Song, C., & McLaughlin-Drubin, M. E. (2017) · Viruses · doi:10.3390/v9090248 · Cited by 127
“In order for a lesion to progress, OIS must be evaded or bypassed, as evidenced by the fact the OIS is observed in premalignant lesions much more than in frank lesions [114].”
BackgroundRegulation of ploidy and senescence by the AMPK‐related kinase NUAK1
Humbert, N., Navaratnam, N., Augert, A., Da Costa, M., Martien, S., Wang, J., Martinez, D., Abbadie, C., Carling, D., de Launoit, Y., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.342 · Cited by 115
“…cells under- go senescence in response to oncogenes has led to the hypo- thesis that senescence, similar to apoptosis (Lowe et al, 2004; Dimri, 2005), is an intrinsic genetic programme with tumour- suppressive properties (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005; Dimri, 2005).”
BackgroundSelf-citationBesancenot, R., Chaligné, R., Tonetti, C., Pasquier, F., Marty, C., Lécluse, Y., Vainchenker, W., Constantinescu, S. N., & Giraudier, S. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000476 · Cited by 106
“Moreover, the senescence process is recognized as a physiologically irreversible mechanism, yet some cancer cells can escape this process [23,24].”
BackgroundAging and induced senescence as factors in the pathogenesis of lung emphysema
Karrasch, S., Holz, O., & Jörres, R. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.013 · Cited by 114
“The involvement of p16 and p53 in maintaining senescence is underscored by the observation that pre-malignant lesions show a loss of these and other senescence markers when turning into malignancy.(125) CDK inhibitors might well be involved in the development of cellular senescence in emphysema.”
Backgroundvan Riggelen, J., Müller, J., Otto, T., Beuger, V., Yetil, A., Choi, P. S., Kosan, C., Möröy, T., Felsher, D. W., & Eilers, M. (2010) · Genes & Development · doi:10.1101/gad.585710 · Cited by 107
Generation of an epigenetic signature by chronic hypoxia in prostate cells
Watson, J. A., Watson, C. J., McCrohan, A., Woodfine, K., Tosetto, M., McDaid, J., Gallagher, E., Betts, D., Baugh, J. A., O'Sullivan, J. N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp307 · Cited by 122
Functional exploration of colorectal cancer genomes using Drosophila
Bangi, E., Murgia, C., Teague, A., Sansom, O. J., & Cagan, R. L. (2016) · Nature Communications · doi:10.1038/ncomms13615 · Cited by 117
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence
Fujita, K., Horikawa, I., Mondal, A. M., Jenkins, L. M. M., Appella, E., Vojtesek, B., Bourdon, J.-C., Lane, D. P., & Harris, C. C. (2010) · Nature Cell Biology · doi:10.1038/ncb2123 · Cited by 103
“Evidence that the p53- and Siah1-mediated downregulation of TRF2 occurs in vivo was obtained from the analysis of human colon adenoma tissues, a pre-malignant tumour associated with p53-mediated cellular senescenc”
BackgroundAutophagy and senescence in cancer therapy
Gewirtz, D. A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24420 · Cited by 107
Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression
Stallings-Mann, M. L., Waldmann, J., Zhang, Y., Miller, E., Gauthier, M. L., Visscher, D. W., Downey, G. P., Radisky, E. S., Fields, A. P., & Radisky, D. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004062 · Cited by 110
“A major barrier to tumor progression is oncogene-induced senescence (OIS), a p19–p53/p16–retinoblastoma protein– dependent mechanism that limits the proliferative capacity of premalignant cells and that has been best defined for the transition from premalignant lung adenoma to malignant LAC (21).”
BackgroundMethodInfluentialDetecting and targeting senescent cells using molecularly imprinted nanoparticles
Ekpenyong-Akiba, A. E., Canfarotta, F., Abd H., B., Poblocka, M., Casulleras, M., Castilla-Vallmanya, L., Kocsis-Fodor, G., Kelly, M. E., Janus, J., Althubiti, M., et al. (2019) · Nanoscale Horizons · doi:10.1039/c8nh00473k · Cited by 108
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
Self-citationReshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 119
Self-citationROS‐generating oxidases Nox1 and Nox4 contribute to oncogenic Ras‐induced premature senescence
Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., Yabe‐Nishimura, C., Tanaka, E., & Kamata, T. (2013) · Genes to Cells · doi:10.1111/gtc.12015 · Cited by 108
“In vitro studies on oncogenic Ras-induced senescence using ectopic expression of activated Ras in primary fibroblasts had been fueled by studies on mouse models of oncogenic Ras-driven tumorigenesis (Collado et al. 2005).”
BackgroundSenescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
Malaquin, N., Vercamer, C., Bouali, F., Martien, S., Deruy, E., Wernert, N., Chwastyniak, M., Pinet, F., Abbadie, C., & Pourtier, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063607 · Cited by 101
“Almost all precancerous cells of benign tumors display senescence markers, which are lost in the subsequent malignant tumors [3,4,5,6].”
BackgroundRas signaling through RASSF proteins
Donninger, H., Schmidt, M., Mezzanotte-Sharpe, J., Barnoud, T., & Clark, G. J. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.06.007 · Cited by 115
Cellular senescence and its role in white adipose tissue
Smith, U., Li, Q., Rydén, M., & Spalding, K. L. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00757-x · Cited by 122
Premature senescence of human endothelial cells induced by inhibition of glutaminase
Unterluggauer, H., Mazurek, S., Lener, B., Hütter, E., EIGENBRODT, E., Zwerschke, W., & Jansen‐Dürr, P. (2008) · Biogerontology · doi:10.1007/s10522-008-9134-x · Cited by 116
“2004), and for certain human tumors, there is now solid evidence that the development of malignant tumors proceeds via a pre-malignant stage that is characterized by the presence of senescent cells in the lesions (Braig et al. 2005; Collado et al. 2005; Michaloglou et al. 2005).”
BackgroundNicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.038 · Cited by 108
“There exists continuing controversy as to whether oncogene-induced growth arrest is a physiological protective mechanism for reducing the incidence of cancer in mammals by disabling cells that have begun to acquire some of the multiple mutations required to establish tumorigenesis, or whether it is just an artifact of…”
BackgroundMicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
Esteban, F. J., Muñoz, M., González‐Moles, M. Á., & Rosso, M. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-8161-9 · Cited by 112
“There is ample evidence that escape from senescence, or immortality, is important for malignant transformation [85].”
Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth
Chesnokova, V., Zonis, S., Rubinek, T., Yu, R., Ben-Shlomo, A., Kovács, K., Wawrowsky, K., & Melmed, S. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0974 · Cited by 116
“www.aacrjournals.org 10569 Cancer Res 2007;67: ( 21 ).”
InfluentialRaf-1 Addiction in Ras-Induced Skin Carcinogenesis
Ehrenreiter, K., Kern, F., Velamoor, V., Meissl, K., Galabova‐Kovacs, G., Sibilia, M. C., & Baccarini, M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.008 · Cited by 115
“Only few K5-SOS-F+ keratinocytes, f/f or D/D of the 129/Sv background, proliferated in complete media (Figure 4A), possibly because of oncogenic stress, which induces growth arrest in premalignant cells (Collado et al., 2005).”
BackgroundEpithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
Smit, M. A., & Peeper, D. S. (2010) · Aging · doi:10.18632/aging.100209 · Cited by 108
Nelson, D. M., Jaber-Hijazi, F., Cole, J. J., Robertson, N. A., Pawlikowski, J. S., Norris, K. T., Criscione, S. W., Pchelintsev, N. A., Piscitello, D., Stong, N., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1017-x · Cited by 106
Cooperation between p21 and Akt is required for p53‐dependent cellular senescence
Kim, Y. Y., Jee, H. J., Um, J., Kim, Y. M., Bae, S. S., & Yun, J. (2017) · Aging Cell · doi:10.1111/acel.12639 · Cited by 106
“While this phenomenon, termed ‘replicative senescence’, is known to contribute to organismal aging processes, another type of cellular senescence, termed ‘premature senescence’ or ‘stress-induced senescence’, is considered a barrier to tumorigenesis because it acts to remove precancerous cells (Collado et al., 2005; C…”
BackgroundBiological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 111
Herbstein, F., Sapochnik, M., Attorresi, A. I., Pollak, C., Senin, S. A., Gonilski‐Pacin, D., del Giudice, N. C., Fiz, M., Elguero, B., Fuertes, M., et al. (2024) · Aging Cell · doi:10.1111/acel.14258 · Cited by 121
“Oncogene-induced senescence (OIS), a particular type of senescence triggered by oncogene activation in the cell, was described in different premalignant lesions in vitro and in vivo (Collado et al., 2005 ).”
BackgroundBach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin
Dohi, Y., Ikura, T., Hoshikawa, Y., Katoh, Y., Ota, K., Nakanome, A., Muto, A., Omura, S., Ohta, T., Ito, A., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1516 · Cited by 110
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Trobridge, P. A., Knoblaugh, S. E., Washington, M. K., Muñoz, N. M., Tsuchiya, K. D., Muñoz-Rojas, A. R., Song, X., Ulrich, C. M., Sasazuki, T., Shirasawa, S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.066 · Cited by 113
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2012) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 97
“OIS arrested cells have been identified in the non-invasive precursor stages of cancer development (Braig et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Bartkova et al., 2006; Courtois-Cox et al., 2006; Di Micco et al., 2006; Dankort et al., 2007; Sun et al., 2007; Halazonetis et…”
InfluentialThe evolving concept of tumor microenvironments
Laconi, E. (2007) · BioEssays · doi:10.1002/bies.20606 · Cited by 98
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Polireddy, K., & Chen, Q. (2016) · Journal of Cancer · doi:10.7150/jca.14922 · Cited by 120
“In precursor lesions, oncogenic K-Ras expression co-exists with P16/CDKN2A and other markers of senescence, while in PDAC, expression of P16/CDKN2A and senescence markers are missing (16).”
BackgroundEating to exit: autophagy-enabled senescence revealed: Figure 1.
White, E., & Lowe, S. W. (2009) · Genes & Development · doi:10.1101/gad.1795309 · Cited by 97
“As a consequence, cellular senescence imposes a potent barrier to tumorigenesis and contributes to the cytotoxicity of certain anti-cancer agents (Schmitt et al. 2002; Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005).”
BackgroundDirect reprogramming by oncogenic Ras and Myc
Ischenko, I., Zhi, J., Moll, U. M., Nemajerová, A., & Petrenko, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219592110 · Cited by 109
“The functional specificity of Ras isoforms can be determined by the amount of transgene expression (8), by the specific regulatory networks controlled by each isoform (4–7), and by their differential abilities to render cells permissive to oncogene-driven proliferation (9, 10).”
BackgroundSelective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Hubackova, S., Davidova, E., Rohlenova, K., Stursa, J., Werner, L., Andera, L., Dong, L., Terp, M. G., Hodny, Z., Ditzel, H. J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0118-3 · Cited by 101
“During tumour development, spontaneous incidence of senescence was detected in premalignant tumours [36].”
BackgroundMolecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Tzadikevitch‐Geffen, K., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100849 · Cited by 99
“…are needed for tumor suppression, restriction of tissue damage, and embryonic development (Serrano et al , 1997; Braig et al , 2005; Chen et al , 2005; Collado et al , 2005; Michaloglou et al , 2005; Krizhanovsky et al , 2008; Chuprin et al , 2013; Munoz-Espin et al , 2013; Storer et al , 2013).”
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Morphological and Functional Characteristic of Senescent Cancer Cells
Sikora, E., Mosieniak, G., & Alicja Sliwinska, M. (2016) · Current Drug Targets · doi:10.2174/1389450116666151019094724 · Cited by 99
Binet, R., Ythier, D., Robles, A. I., Collado, M., Larrieu, D., Fonti, C., Brambilla, E., Brambilla, C., Serrano, M., Harris, C. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1016 · Cited by 101
“Analysis of the expression of WNT16B in mouse tumor samples was performed by immunohistochemical staining of lungs from activated 7- to 9-mo-old K-Ras mice (18).”
BackgroundMethodInfluentialSelf-citationCellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 91
“Cellular senescence appears to be acting as a barrier to cancer, preventing damaged cells from undergoing aberrant proliferation [4-10].”
BackgroundNguyen, A. T., Emelyanov, A., Koh, C. H. V., Spitsbergen, J. M., Lam, S. H., Mathavan, S., Parinov, S., & Gong, Z. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007831 · Cited by 108
“as a marker that is specifically associated to OIS (Collado et al., 2005), was extremely up-regulated in krasV12 HL.”
Senescent tumor cells: an overlooked adversary in the battle against cancer
Park, S. S., Choi, Y. W., Kim, J., Kim, H. S., & Park, T. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00717-5 · Cited by 113
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Li, S. K. M., Smith, D. K., Leung, W. Y., Cheung, A. M. S., Lam, E. W. F., Dimri, G. P., & Yao, K.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709604200 · Cited by 97
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas, A., Kelly, G. L., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00996-z · Cited by 110
“Moreover, c-MYC over-expression can cause OIS through the transcriptional induction of p14ARF, which in turn leads to the activation of TP53 through the inhibition of MDM2 [66, 67] (Fig.”
BackgroundThe stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression
Schramek, D., Kotsinas, A., Meixner, A., Wada, T., Elling, U., Pospisilik, J. A., Neely, G. G., Zwick, R. H., Sigl, V., Forni, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.767 · Cited by 115
“As Ras promotes oncogene-induced senescence (OIS) by activating CHK2 in vitro and in vivo”
Self-citationCellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 107
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 106
The Histone Code of Senescence
Paluvai, H., Di Giorgio, E., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 93
“Mice develop lung adenomas characterized by the accumulation of senescent cells [95].”
BackgroundFilippi-Chiela, E. C., Silva, M. M. B. E., Thomé, M. P., & Lenz, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1009795 · Cited by 98
Control of cellular senescence by CPEB
Groisman, I., Ivshina, M., Marin, V., Kennedy, N. J., Davis, R. J., & Richter, J. D. (2006) · Genes & Development · doi:10.1101/gad.1438906 · Cited by 94
“In vivo, senescence may be a tumor-suppression mechanism to prevent malignant transformation (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005) and contribute to organismal aging (Patil et al.”
BackgroundZhao, Y., Tyshkovskiy, A., Muñoz-Espín, D., Tian, X., Serrano, M., de Magalhaes, J. P., Nevo, E., Gladyshev, V. N., Seluanov, A., & Gorbunova, V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721160115 · Cited by 92
“CS is believed to be an important mechanism to prevent cancer (3, 4).”
BackgroundSelf-citationBastid, J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9344-6 · Cited by 99
“was shown for senescence in premalignant lesions [31].”
BackgroundWu, C.-H., Sahoo, D., Arvanitis, C., Bradon, N., Dill, D. L., & Felsher, D. W. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000090 · Cited by 95
“Indeed, we did find that senescence associated genes such as p15INK4b, p21CIP, PCNA, MCM3, CYCLIN A [12,30,31] were Author Summary”
BackgroundCellular senescence and chromatin organisation
Narita, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603636 · Cited by 95
“These data suggest that an initial oncogenic lesion promotes hyperproliferation in the tissues, but subsequent provocation of OIS contributes to restrict tumour progression from a benign to a malignant state.”
BackgroundInfluentialTranscriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
“However, the fact that EZH2 is known to be mutated and inactivated in myeloid disorders (Ernst et al., 2010) suggests that Oncogene EZH2-targeting drugs may only be effective in a subset of tumour types.”
InfluentialCOX2 regulates senescence secretome composition and senescence surveillance through PGE2
Gonçalves, S., Yin, K., Ito, Y., Chan, A., Olan, I., Gough, S., Cassidy, L., Serrao, E., Smith, S., Young, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108860 · Cited by 95
“We next studied Cox2 expression in murine Kras-driven PanIN, which was previously reported to show evidence of senescence (Collado et al., 2005; Hingorani et al., 2003).”
BackgroundCellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
The evolution and ecology of benign tumors
Boutry, J., Tissot, S., Újvári, B., Capp, J., Giraudeau, M., Nedelcu, A. M., & Thomas, F. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188643 · Cited by 113
Zampetidis, C. P., Galanos, P., Angelopoulou, A., Zhu, Y., Polyzou, A., Karamitros, T., Kotsinas, A., Lagopati, N., Mourkioti, I., Mirzazadeh, R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.017 · Cited by 87
Hafner, C. M., Toll, A., Fernández-Casado, A., Earl, J., Marqués, M., Acquadro, F., Méndez‐Pertuz, M., Urioste, M., Malats, N., Burns, J. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008365107 · Cited by 102
“0 β-galactosidase activity and expression of senescence markers (p14, p16, p53, Dec1, HP-1γ, and H3K9me3) were assessed (35).”
BackgroundGrowth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Wu, P., Becker, A., & Park, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155436 · Cited by 98
Kolodkin-Gal, D., Roitman, L., Ovadya, Y., Azazmeh, N., Assouline, B., Schlesinger, Y., Kalifa, R., Horwitz, S., Khalatnik, Y., Hochner-Ger, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-321112 · Cited by 92
The redox-senescence axis and its therapeutic targeting
Ngoi, N. Y., Liew, A. Q., Chong, S. J. F., Davids, M. S., Clement, M.-V., & Pervaiz, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102032 · Cited by 88
dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene‐induced senescence
Santinon, G., Brian, I., Pocaterra, A., Romani, P., Franzolin, E., Rampazzo, C., Bicciato, S., & Dupont, S. (2018) · The EMBO Journal · doi:10.15252/embj.201797780 · Cited by 100
“…GSE59522 and GSE60652 for Ras activation in IMR90 primary human fibroblasts (Young et al , 2009; Takebayashi et al , 2015); GSE2487 for MEK activation in IMR90 primary human fibroblasts (Collado et al , 2005); GSE46801 for BRAF activation in primary human melanocytes (Pawlikowski et al , 2013).”
Noncoding RNA control of cellular senescence
Abdelmohsen, K., & Gorospe, M. (2015) · WIREs RNA · doi:10.1002/wrna.1297 · Cited by 90
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence
Cheng, Y., Wang, S., Zhang, H., Lee, J.-S., Ni, C., Guo, J., Chen, E., Wang, S., Acharya, A., Chang, T.-C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.019 · Cited by 98
“Indeed, many different types of pre-cancerous lesions show signs of senescence, including p16 INK4A expression and senescence-associated b -galactosidase activity (SA-b -gal), 4 while more advanced tumors typically lose these markers.”
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
“Cellular senescence induced by several oncogenes often causes a global alteration in chromatin structure [33, 91].”
BackgroundInfluential
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.